thiazoles has been researched along with C gattii Infection in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Barros, PP; de Oliveira, RB; de Sá, NP; Johann, S; Junqueira, JC; Rosa, CA; Santos, DA; Vaz, JA | 1 |
| Borelli, BM; de Oliveira Fernandes, P; de Oliveira, RB; Gonçalves de Souza, I; Johann, S; Lino, CI; Maltarollo, VG; Maria de Souza Fagundes, E; Ramos, JP; Santos Teixeira, IN; Silvério Matos, TT | 1 |
| Gil-Lamaignere, C; Müller, FM; Zhu, LP | 1 |
| Aperis, G; Mylonakis, E | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T | 1 |
| Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T | 1 |
| Clancy, CJ; Nguyen, MH | 1 |
| Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T | 1 |
1 review(s) available for thiazoles and C gattii Infection
| Article | Year |
|---|---|
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole | 2006 |
7 other study(ies) available for thiazoles and C gattii Infection
| Article | Year |
|---|---|
Thiazole derivatives act on virulence factors of Cryptococcus spp.
Topics: Animals; Antifungal Agents; Biofilms; Cells, Cultured; Cryptococcosis; Cryptococcus; Disease Models, Animal; Fungal Polysaccharides; Larva; Macrophages; Mice; Molecular Structure; Moths; Phagocytosis; Survival Analysis; Thiazoles; Virulence Factors | 2019 |
Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.
Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus; HEK293 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Paracoccidioides; Paracoccidioidomycosis; Structure-Activity Relationship; Thiazoles | 2018 |
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles | 2004 |
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles | 1996 |
Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Coloring Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Spectrophotometry; Tetrazolium Salts; Thiazoles | 1997 |
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2000 |